Mainz Biomed insider reports 643,850 share holding

Mainz Biomed N.V. disclosed an insider ownership position through a Form 3 filing.

Accepted by SEC EDGAR 01/16/2026 - 03:37 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Mainz Biomed N.V. disclosed an insider ownership position through a Form 3 filing. Donahue Kevin Michael, identified as a 10% owner of the company, reported beneficial ownership of 643,850 shares of common stock, held directly. The event date for this ownership report is 10/17/2025. This filing serves as an initial statement of his existing holdings rather than detailing a new stock transaction.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Donahue Kevin Michael

Role 10% Owner

Type	Security	Shares	Price	Value
Holding	Common Stock	--	--	--

Holdings: Common Stock — 643,850 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Mainz Biomed (MYNZ) Form 3 filing disclose?

The Form 3 filing discloses that 10% owner Donahue Kevin Michael beneficially owns 643,850 shares of Mainz Biomed N.V. common stock, held directly.

How many Mainz Biomed (MYNZ) shares does the insider report owning?

The insider reports direct beneficial ownership of 643,850 shares of Mainz Biomed N.V. common stock following the reported event.

What is the event date for this Mainz Biomed (MYNZ) insider ownership report?

The date of the event requiring the Form 3 statement is listed as 10/17/2025.

Is this Mainz Biomed (MYNZ) Form 3 reporting a trade or just holdings?

This Form 3 functions as an initial statement of beneficial ownership, listing that 643,850 common shares are owned directly, rather than describing a specific stock trade.

What is the insider’s relationship to Mainz Biomed (MYNZ)?

In the insider data, Donahue Kevin Michael is identified as a 10% owner of Mainz Biomed N.V..

How are the Mainz Biomed (MYNZ) shares held by the insider classified?

The 643,850 common shares are reported with an ownership form of Direct (D), indicating they are directly held by the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Donahue Kevin Michael

(Last) (First) (Middle)

2502 KIRBY STREET

(Street)

DALLAS TX 75204

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/17/2025

3. Issuer Name and Ticker or Trading Symbol
MAINZ BIOMED N.V. [ MYNZ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	643,850	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Kevin Donahue	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.